Antonella Bruzzese Selected Research

Thrombophilia

9/2019

Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: a single-center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonella Bruzzese Research Topics

Disease

9	Multiple Myeloma 03/2024 - 01/2022
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2020
3	Hematologic Neoplasms (Hematological Malignancy) 09/2020 - 01/2019
2	Neoplasms (Cancer) 05/2024 - 10/2023
2	Anemia 04/2024 - 10/2023
2	Disease Progression 01/2024 - 10/2023
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2023 - 01/2023
2	Thrombotic Thrombocytopenic Purpura 07/2023 - 04/2023
2	Thrombosis (Thrombus) 09/2020 - 04/2020
1	Primary Myelofibrosis (Myelosclerosis) 04/2024
1	Leukemia 01/2024
1	Thrombotic Microangiopathies 07/2023
1	COVID-19 07/2023
1	Iron Overload 05/2023
1	Hyperplasia 05/2023
1	Infections 10/2020
1	Pulmonary Alveolar Proteinosis 10/2020
1	Sepsis (Septicemia) 09/2020
1	Thrombocytopenia (Thrombopenia) 04/2020
1	Venous Thromboembolism 09/2019
1	Thrombophilia 09/2019

Drug/Important Bio-Agent (IBA)

6	Lenalidomide (CC 5013)FDA Link 01/2024 - 01/2022
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2022
5	elotuzumabIBA 01/2023 - 01/2022
3	carfilzomibIBA 12/2022 - 01/2022
2	Proteasome InhibitorsIBA 10/2023 - 01/2023
2	thiamine triphosphorate (TTP)IBA 07/2023 - 04/2023
2	caplacizumabIBA 07/2023 - 04/2023
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2020 - 09/2019
1	fms-Like Tyrosine Kinase 3IBA 05/2024
1	CytokinesIBA 04/2024
1	Janus Kinase InhibitorsIBA 04/2024
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2024
1	selinexorIBA 03/2024
1	tagraxofuspIBA 10/2023
1	Immunomodulating AgentsIBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	luspaterceptIBA 10/2023
1	ivosidenibIBA 09/2023
1	zanubrutinibIBA 09/2023
1	glasdegibIBA 09/2023
1	belantamab mafodotinIBA 05/2023
1	IronIBA 05/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2023
1	Chelating AgentsIBA 05/2023
1	Deferasirox FDA Link 05/2023
1	DeferiproneIBA 05/2023
1	acalabrutinibIBA 01/2023
1	venetoclaxIBA 01/2023
1	pomalidomideIBA 01/2023
1	isatuximabIBA 01/2023
1	Surface-Active Agents (Surfactants)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	Fondaparinux (Arixtra)FDA Link 04/2020
1	AnticoagulantsIBA 04/2020
1	AntithrombinsIBA 09/2019

Therapy/Procedure

6	Therapeutics 05/2024 - 01/2019
3	Drug Therapy (Chemotherapy) 10/2023 - 09/2020
3	Salvage Therapy 12/2022 - 01/2022
3	Catheters 09/2020 - 01/2020
1	Hematopoietic Stem Cell Transplantation 10/2020
1	Central Venous Catheters 09/2020
1	Parenteral Nutrition 09/2020